Well this is very disappointing!
SP will drop significantly when it opens and not just because of the raise price but because sales are bad.
Management have dropped the ball with the negative growth in China.
Also worldwide there is 0 organic growth.
I suppose if I had early signs of Glaucoma and the doctor said "I can stick a needle in your eye or you can just take eye drops", I'd take the eye drops.
I'm not selling out though, I'll give it 6 months and see if management can improve their performance.
News: EYE Nova Eye Medical To Raise A$8M For Expansion Of Glaucoma Surgical Device Business, page-31
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.010(6.06%) |
Mkt cap ! $35.50M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 15.5¢ | $58.82K | 372.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14029 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 83525 | 2 |
View Market Depth
| Last trade - 15.44pm 04/11/2024 (20 minute delay) ? |
| EYE (ASX) Chart |